SPOTLIGHT
BWH NeuroTechnology Studio
Located within the Hale Building at BWH, the NeuroTechnology Studio (NTS) is hosted by the Department of Neurology, with a mission to support neuroscience and related research throughout the local community, within and beyond BWH. Resources include confocal and wide-field microscopes, an Agilent Seahorse XFe96 for metabolic studies, an Illumina Nextseq DNA sequencer, and a 10X Chromium Controller for droplet-based analysis. We have also recently acquired a 2-photon imaging system that is currently being set up and tested and which will become available once the initial phase is complete. The NTS also operates the Genomics and Bioinformatics Hub (http://bioinformatics.bwh.harvard.edu), a fee-based consulting and data analysis service that provides collaborative support for computational analysis of 'omics data. Core staff provide training and assistance for all users, and also run seminars and workshops in optical microscopy, image analysis and genomics.
The BWH Seahorse core
The BWH Seahorse core supports the use of an Agilent Seahorse XFe24 Extracellular Flux Analyzer to perform sensitive measurements of oxygen consumption rate and extracellular acidification rate in cultured cells, tissues, or model organisms. Our goals are to develop an independent user base while connecting the broader metabolism research community. We help users design the experiments, perform the assays, and analyze the data. We can provide reagents for commonly performed Mitochondrial and Glycolytic Stress Assays or users can provide their own reagents for customized experiments. We hope to facilitate the bioenergetic characterization of model systems using this increasingly popular and important technology.
The Clinical Pharmacology Core
The Clinical Pharmacology Core provides services required to undertake clinical and nonclinical pharmacokinetic studies. The Core is located in rooms 1021-1029 of the Jackson Building on the MGH main campus. It offers considerable experience with LC-MS/MS based assays for drugs that are low molecular weight organic molecules, including peptides and small proteins, in biological fluids. Assays for nearly 50 investigational and approved anticancer drugs have been established for early phase clinical trials. Procedures have been implemented to assure that laboratory operations conform to the standards expected by the pharmaceutical industry and health authorities. Comprehensive pharmacokinetic data analysis by noncompartmental or model-dependent methods is also offered as a service. Investigators involved in drug development for therapeutic indications other than cancer are encouraged to consider utilizing the Core.
EXPLORE OUR CORES
ABOUT US
Research core facilities at Mass General Brigham bring state-of-the-art instrumentation, methodologies and expertise crucial to the promotion of research on our campuses and beyond. There are over eighty cores, across the Mass General Brigham Hospital network, established to share their expertise, facilities and equipment in order to efficiently use resources, promote collaboration, and further enhance the competitiveness of MGB investigators to secure research funding.
The Core Management System provides Core users with one stop shopping of all Partners cores on the system. Core users have the ability to create user accounts to manage funding, request services and check the status of requests at their own convenience. The system is in the early stages of implementation so be sure to check back regularly to see what Cores have been added.
To download a Quick Guide to Using the Core Management System.
10475 Users
159 Cores
2251 Services
RESEARCH CORE FACILITIES TEAM
Ramesh Narayanaswamy, PhD
Senior Manager
Ramesh earned his PhD in Biochemistry from U. Mass Medical School and joined the Division of Immunology, Boston Children's Hospital (BCH) as Post-doctoral fellow. He remained with the Division of Immunology, BCH for over two decades as a PI and as the Director of Laboratory Research for seven years. His main research focus was on the molecular basis of Primary Immune Deficiency diseases with emphasis on the role of actin cytoskeleton in T cell function. Ramesh has published over 60 original papers, book chapters and reviews. He left research to join Research Administration at BCH and moved to Research Core Facilities Office in December 2014.
Yovani Edwards
Senior Analyst
Yovani Edwards Is a Senior Financial Analyst at the Research Core Facilities Office. She has been with the Office since 2011 and believes that the past years as a Financial Analyst at Mass General Brigham has been a great learning experience and a wonderful way to help the research community. She on the board of the Directors (Treasurer) for Community Alliance. Yovani graduated with a Master's degree in Finance from Bentley University. In her free time, she enjoys reading and watching Documentaries.
Jessica Cho
Senior Analyst
Jessica is a Senior specialist at the Research Core Facilities Office. Jessica is from West Warwick, Rhode Island. She graduated from the University of Connecticut with a major in Biomedical Engineering. After her graduation she joined Mass General Brigham as part of their Research Management cohort training program and at the completion she was appointed as a specialist with Research Cores Facilities Office. She is a candidate at Boston University for a Master's in Business Administration with a focus on the Healthcare System.
Tera Morse
Financial Analyst
Tera Morse is a Senior Financial Analyst at the Research Core Facilities Office. She started with the Office in May of 2017. She graduated from the University of New Brunswick (Canada) with a Bachelor of Arts Degree and Bachelor of Law Degree. After practicing law as an attorney in New Brunswick for over four years, she moved to Boston and completed her Masters of Business Administration degree with a concentration in Finance at Suffolk University.
